SPOTLIGHT

COVID-19
News

Find the most recent news about COVID-19 research conducted by our clinician scientists, researchers, innovators and faculty.
Helmet May Help COVID-19 Patients Avoid Intubation
April 14, 2020 - The most severe COVID-19 patients may require intubation, which can put health care providers at risk. When seeking clinical alternatives to intubation, the innovative "helmet" offers a promising option.
EnMed Produces an N95 Alternative
March 26, 2020 - As cases of COVID-19 increased and the nation put out a call for PPE, Houston Methodist worked with its engineering partners at Texas A&M University to create a 3D-printed alternative to conventional N95 masks.
EnMed Collaborates on Inhaler Device
April 8, 2020 - Houston Methodist leveraged their EnMed collaboration with Texas A&M University to develop a 3D printed spacer that can be attached to an inhaler.
GeneOne Life Science and Houston Methodist to Develop a COVID-19 Vaccine
March 17, 2020 - Houston Methodist researchers are partnering with GeneOne Life Science Inc. to develop an RNA vaccine against COVID-19, the novel coronavirus that has caused a global pandemic.
April 16, 2020 - Early results encourage the clinical research team conducting clinical trials of Gilead Sciences’ antiviral drug Remdesivir. Methodist Hospital was the first clinical trial site in Houston to test the antiviral drug.
Favipiravir clinical trial
Antiviral Offers Outpatient Treatment Option July 27, 2020 - An antiviral drug, favipiravir, previously approved in Japan to treat influenza, is now under clinical investigation at Houston Methodist to treat the SARS-CoV-2 coronavirus. The Phase 2, multicenter, randomized trial is sponsored by Fujifilm Pharmaceuticals U.S.A., Inc.
First Plasma Therapy Fast-Tracked by FDA
March 28, 2020 - Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.
FDA Fast-Tracks RLF-100 Trial for Treating ARDS June 24, 2020 - Jihad Georges Youssef, MD, professor of clinical medicine, Department of Medicine, and transplant pulmonologist, J.C. Walter Jr. Transplant Center, is leading a multi-center clinical trial fast-tracked by the FDA to test a treatment for acute lung injury and, specifically, acute respiratory distress syndrome (ARDS) associated with COVID-19.
Health provider burnout study
Facing the Unseen Crisis: Health Provider Burnout July 20, 2020 - During the initial peak of COVID-19, Houston Methodist researchers shared their expertise on ICU staff burnout in a study on "Provider Burnout and Fatigue during the COVID-19 Pandemic: Lessons Learned from a High-Volume Intensive Care Unit." Published in April, it remains among Altmetric's most popular publications.
Copyright 2020. Houston Methodist, Houston, TX. All rights reserved. Privacy & Disclaimer | Sign Up for Our Monthly Newsletter
FOLLOW US
Methodology_Online_logoHoustonMethodistLogoWhite
image.svgmagnifying-glass.svg
close-24px__1_.svg